Leslie Gold

LeslieGold_CalRegen

Tissue Regeneration Sciences, Inc (TRS)

2018

Affiliations

New York University

Technologies

Therapeutic

Indication

Basic Research

Clinical Research

Dermatology

Drug Discovery

Fibrosis

Personalized Medicine

Regenerative Medicine

Tissue Regeneration Sciences, Inc (TRS) is a start-up biotechnology company formed on the discovery of calreticulin (CRT), as a novel biotherapeutic that has unique, diverse and broad ranging tissue regenerative qualities that will be developed for different indications including chronic wound healing, epidermal appendage (hair follicle) neogenesis, improving the cosmetic architecture of the skin, and healing of ophthalmic ulcers.

 

Newsletter Signup

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Corporate Supporters

Program of

Initiated by